These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 9419440

  • 1. Treatment of autoimmune diseases through manipulation of antigen presentation.
    Spack EG.
    Crit Rev Immunol; 1997; 17(5-6):529-36. PubMed ID: 9419440
    [Abstract] [Full Text] [Related]

  • 2. Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen-Ia complex.
    Aharoni R, Teitelbaum D, Arnon R, Puri J.
    Nature; 1991 May 09; 351(6322):147-50. PubMed ID: 1709449
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS, Andersson EC, Jansson L, krogsgaard M, Andersen CB, Engberg J, Strominger JL, Svejgaard A, Hjorth JP, Holmdahl R, Wucherpfennig KW, Fugger L.
    Nat Genet; 1999 Nov 09; 23(3):343-7. PubMed ID: 10610182
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM, Arnold PY, White GA, Nardella JP, Mannie MD.
    J Immunol; 1999 Nov 15; 163(10):5201-10. PubMed ID: 10553040
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Competitive inhibition of antigen presentation in animal models of autoimmune disease.
    Lock C, Smilek D, Gautam A, Vaysburd M, Dwivedy S, McDevitt H.
    Semin Immunol; 1991 Jul 15; 3(4):247-55. PubMed ID: 1718485
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes.
    Bischof F, Wienhold W, Wirblich C, Malcherek G, Zevering O, Kruisbeek AM, Melms A.
    Proc Natl Acad Sci U S A; 2001 Oct 09; 98(21):12168-73. PubMed ID: 11593032
    [Abstract] [Full Text] [Related]

  • 20. T-cell receptor peptides as immunotherapy for autoimmune disease.
    Gold DP, Shroeder K, Golding A, Brostoff SW, Wilson DB.
    Crit Rev Immunol; 1997 Oct 09; 17(5-6):507-10. PubMed ID: 9419437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.